{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:31:57Z","timestamp":1759332717736},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.lungcan.2011.09.014","type":"journal-article","created":{"date-parts":[[2011,10,27]],"date-time":"2011-10-27T13:35:03Z","timestamp":1319722503000},"page":"84-88","source":"Crossref","is-referenced-by-count":17,"title":["Long acting somatostatin analogues in combination to antineoplastic agents in the treatment of small cell lung cancer patients"],"prefix":"10.1016","volume":"76","author":[{"given":"K.","family":"Zarogoulidis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Eleftheriadou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Th.","family":"Kontakiotis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Gerasimou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Zarogoulidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Sapardanis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Galaktidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Sakkas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gotzamani-Psarrakou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Karatzas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2011.09.014_bib0005","series-title":"Gastrointestinal endocrinology","first-page":"286","article-title":"Somatostatin","author":"Newman","year":"1987"},{"key":"10.1016\/j.lungcan.2011.09.014_bib0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.mce.2007.12.002","article-title":"Somatostatin, cortistatin and their receptors in tumours","volume":"286","author":"Volante","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.lungcan.2011.09.014_bib0015","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1530\/eje.1.02313","article-title":"Quantitative analysis of somatostatin receptor subtype (SST1\u20135) gene express levels in somatostropinomas and non-functioning pituitary adenomas","volume":"156","author":"Taboada","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"Suppl. 2","key":"10.1016\/j.lungcan.2011.09.014_bib0020","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000049163","article-title":"Somatostatin, its receptors and analogs, in lung cancer","volume":"47","author":"O\u2019Byrne","year":"2001","journal-title":"Chemotherapy"},{"key":"10.1016\/j.lungcan.2011.09.014_bib0025","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.mce.2008.02.002","article-title":"Antitumour effects of somatostatin","volume":"286","author":"Pyronnet","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.lungcan.2011.09.014_bib0030","doi-asserted-by":"crossref","first-page":"731","DOI":"10.4161\/cbt.3.8.1030","article-title":"Somatostatin and cancer: applying endocrinology to oncology","volume":"3","author":"Grimberg","year":"2004","journal-title":"Cancer Biol Ther"},{"issue":"December (3)","key":"10.1016\/j.lungcan.2011.09.014_bib0035","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1677\/JOE-10-0342","article-title":"Somatostatin and dopamine receptor interaction in prostate and lung cancer cell lines","volume":"207","author":"Arvigo","year":"2010","journal-title":"J Endocrinol"},{"key":"10.1016\/j.lungcan.2011.09.014_bib0040","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0163-7258(93)90009-3","article-title":"Somatostatin analogs for diagnosis and treatment of cancer","volume":"60","author":"Weckbecker","year":"1993","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.lungcan.2011.09.014_bib0045","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/nrd1255","article-title":"Opportunities in somatostatin research: biological, chemical and therapeutic aspects","volume":"2","author":"Weckbecker","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.lungcan.2011.09.014_bib0050","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/0959-8049(96)00078-0","article-title":"Somatostatin receptor imaging in small cell lung cancer","volume":"32","author":"Berenger","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.lungcan.2011.09.014_bib0055","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000051858","article-title":"OctreoTher: ongoing early clinical development of a somatostatin-receptor-targeted radionuclide antineoplatis therapy","volume":"62","author":"Smith","year":"2000","journal-title":"Digestion"},{"issue":"2","key":"10.1016\/j.lungcan.2011.09.014_bib0060","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0024-3205(94)90107-4","article-title":"Characterization of somatostatin receptors and growth inhibition by the somatostatin analogue BIM23014 in small cell lung carcinoma xenograft: SCLC-6","volume":"55","author":"Pr\u00e9vost","year":"1994","journal-title":"Life Sci"},{"key":"10.1016\/j.lungcan.2011.09.014_bib0070","first-page":"5969","article-title":"Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas","volume":"50","author":"Reubi","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2011.09.014_bib0075","first-page":"471","article-title":"Distribution of somatostatin receptors in normal and neoplastic human tissues: recent advances and potential relevance","volume":"70","author":"Reubi","year":"1997","journal-title":"Yale J Biol Med"},{"issue":"7","key":"10.1016\/j.lungcan.2011.09.014_bib0080","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/aje\/kwg020","article-title":"Allergy, atopy, and cancer: a prospective study of the 1981 Busselton cohort","volume":"157","author":"Talbot-Smith","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.lungcan.2011.09.014_bib0085","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/ijc.1223","article-title":"Somatostatin inhibits the production of vascular endothelial growth factor in human glioma cells","volume":"92","author":"Mentlein","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lungcan.2011.09.014_bib0090","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1200\/JCO.2005.06.081","article-title":"Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis","volume":"23","author":"Hicklin","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2011.09.014_bib0095","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1158\/1078-0432.CCR-06-2186","article-title":"The potential of antiangiogenic therapy in non-small cell lung cancer","volume":"13","author":"Giaccone","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2011.09.014_bib0100","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra0706596","article-title":"Tumor angiogenesis","volume":"358","author":"Kerbel","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lungcan.2011.09.014_bib0135","doi-asserted-by":"crossref","unstructured":"Sun LC, Coy DH., Somatostatin receptor-targeted anti-cancer therapy. Curr Drug Deliv. 2011 Jan;8(1):2-10. Review.","DOI":"10.2174\/156720111793663633"},{"key":"10.1016\/j.lungcan.2011.09.014_bib0110","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000227526","article-title":"Immunohistochemical detection of bcl-2 protein in small cell carcinomas","volume":"53","author":"Yan","year":"1996","journal-title":"Oncology"},{"key":"10.1016\/j.lungcan.2011.09.014_bib0115","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/path.1711770206","article-title":"Expression of bcl-2 oncogene protein is prevalent in small cell lung carcinomas","volume":"177","author":"Jiang","year":"1995","journal-title":"J Pathol"},{"key":"10.1016\/j.lungcan.2011.09.014_bib0120","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1200\/JCO.2005.05.1474","article-title":"Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: the Tarceva Lung Cancer Investigation Trial","volume":"25","author":"Gatzemeier","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2011.09.014_bib0125","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1200\/JCO.2005.02.840","article-title":"TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer","volume":"23","author":"Herbst","year":"2005","journal-title":"J Clin Oncol"},{"issue":"9674","key":"10.1016\/j.lungcan.2011.09.014_bib0130","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(09)60569-9","article-title":"Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial","volume":"373","author":"Pirker","year":"2009","journal-title":"Lancet"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500211004831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500211004831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T04:50:17Z","timestamp":1543467017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500211004831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0169500211004831"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2011.09.014","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}